diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Individuals with T2DM aged more than 18 years (adult, older adult) of both sexes and attending the outpatient clinic were eligible for the study.
Exclusion criteria
Exclusion criteria: Any pregnant patients with diabetes, patients currently using medications (like diabetogenic immunosuppressants or antidepressants) that may affect blood glucose levels at the time of the study any patients who were unable to communicate were excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| changes in Fasting blood glucose, HbA1c levels. Other primary outcome measures included diabetic patients' KAP results, adherence, satisfaction, QoL scores, diabetes-related markers like BMI, LDL, HDL, TC, TG, BP, Scr, and BUN and urine analysis; for the presence of proteinuria. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Percentage of patients complying with annual lipid testing 2. Percentage of patients compliant with statin therapy 3. Percentage of patients achieving a blood pressure goal of less than 140/90 at the end of the trial period 4. Percentage of patients compliant with annual retinopathy examination 5. Percentage of patients compliant with annual nephropathy examination 6. Percentage of patients who had proteinuria and were taking a kidney-sparing agent (e.g., angiotensin-converting-enzyme inhibitor, angiotensin-receptor blocker, or calcium channel blocker) by study end. | — |
Countries
Sudan
Contacts
assistant professor